To the Editor: We share many of the concerns regarding the need for proper oversight in conducting and transparency in reporting the results of human studies expressed in the Editorial by Drs Fergusson and McIntyre.1 We agree with them and with Dr Natanson and colleagues2 that some of the large clinical HBOC trials might have been halted if the results of previous animal and human studies showing risk were known. However, we feel that the Editorial did not put into proper perspective the risk associated with allogeneic blood transfusion.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.